News
The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...
12h
Stockhead on MSNIsland fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ virusesIsland will now focus on using the FDA’s animal rule to advance the Galidesivir program towards a new drug application (NDA), ...
10h
Stockhead on MSNHealth Check: POTUS puts drug tariffs back on agenda… another case of TACO?Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...
The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett. 323, 183–187 (1993).
9h
Stockhead on MSNLunch Wrap: ASX hits the brakes, rotating into defensive stocksThe ASX has fallen 0.31pc by lunchtime in the east, sliding as traders rotate into defensive utilities stocks.
Wild Africa, a conservation nonprofit, has called for urgent and consistent action to reduce the risk of future pandemics by ...
The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...
As the world marks World Zoonoses Day today, Wild Africa is calling for urgent and consistent action to reduce the risk of ...
Rospotrebnadzor has strengthened its systematic approach to delivering medical assistance and currently collaborates with more than 30 countries across four continents ...
Several recent developments point to Kigali’s growing role in Africa’s biopharmaceutical landscape. Rwanda has positioned itself as a strategic hub through a combination of investment in scientific ...
CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results